Eledon Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $205.6M
- as of Sep 30, 2026
- Enterprise Value
- $182.8M
- Shares Outstanding
- 81.3M
- Free Float
- 77.4%
Income Statement
- Net Income
- -$45.6M
Balance Sheet
- Cash & Equivalents
- $22.8M
- Total Debt
- $0
- Net Cash
- $22.8M
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges